mouse anti mouse nk1 1 monoclonal antibody (Bio X Cell)
96
Structured Review
Bio X Cell
mouse anti mouse nk1 1 monoclonal antibody
Mouse Anti Mouse Nk1 1 Monoclonal Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 608 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+mouse+nk1+1/InVivoMAb+anti-mouse+NK1%2E1/pm41922374-372-15-21
Average 96 stars, based on 608 article reviews
Mouse Anti Mouse Nk1 1 Monoclonal Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 608 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+mouse+nk1+1/InVivoMAb+anti-mouse+NK1%2E1/pm41922374-372-15-21
Average 96 stars, based on 608 article reviews
mouse anti mouse nk1 1 monoclonal antibody - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Mouse Assay:Article Title: IL-1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma Article Snippet: .. Mice were injected intraperitoneally (i.p.) with 200 μg of specific monoclonal antibodies or inhibitors: anti-mouse CD8, InVivoPlus, clone YTS169.4 (BioXCell Cat. BP0117, RRID:AB_2894806) and the relative isotype control rat IgG2b, InVivoPlus, clone LTF-2 (BioXCell Cat. BP0090, RRID:AB_1107780); Injection:Article Title: IL-1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma Article Snippet: .. Mice were injected intraperitoneally (i.p.) with 200 μg of specific monoclonal antibodies or inhibitors: anti-mouse CD8, InVivoPlus, clone YTS169.4 (BioXCell Cat. BP0117, RRID:AB_2894806) and the relative isotype control rat IgG2b, InVivoPlus, clone LTF-2 (BioXCell Cat. BP0090, RRID:AB_1107780); Article Title: Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression Article Snippet: Anti-Mouse Asialo-GM1 (Injected 100 μg/mouse, once a week) , Biolegend , 146002 RRID: AB_2562206. .. Article Title: A STING agonist potentiates C1 lipidoid-based mRNA cancer vaccine through promoting TNF-α secretion in vivo. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Bioprocessing:Article Title: IL-1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma Article Snippet: .. Mice were injected intraperitoneally (i.p.) with 200 μg of specific monoclonal antibodies or inhibitors: anti-mouse CD8, InVivoPlus, clone YTS169.4 (BioXCell Cat. BP0117, RRID:AB_2894806) and the relative isotype control rat IgG2b, InVivoPlus, clone LTF-2 (BioXCell Cat. BP0090, RRID:AB_1107780); Control:Article Title: IL-1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma Article Snippet: .. Mice were injected intraperitoneally (i.p.) with 200 μg of specific monoclonal antibodies or inhibitors: anti-mouse CD8, InVivoPlus, clone YTS169.4 (BioXCell Cat. BP0117, RRID:AB_2894806) and the relative isotype control rat IgG2b, InVivoPlus, clone LTF-2 (BioXCell Cat. BP0090, RRID:AB_1107780); Article Title: Cryoablation Activates the cGAS-STING-CXCL10 Axis in Macrophages to Enhance Anti-Tumor Immunity in NSCLC. Article Snippet: For T cell depletion, anti-mouse CD8 α (Selleck, A2102), anti-mouse CD4 (Selleck, A2101), or IgG2b isotype control (Selleck, A2116) was administered intraperitoneally at 200 μL per mouse. .. For NK cell depletion, Article Title: Physiological activation of Aryl hydrocarbon receptor by food-derived ligands is essential for the efficacy of anti-PD1 therapy Article Snippet: .. For in vivo NK cell depletion, mice were treated intra-peritoneally with 120 μg of Article Title: DNA delivered by lipid nanoparticles induces CD8 + T cell–dependent antitumor responses and enhances anti–PD-L1 therapy Article Snippet: .. The following dosing materials were purchased for the study: ADU-S100 from MedChemExpress and InVivoMAb rat IgG2a isotype control (BE0089, clone 2A3), anti-mouse CD8α (BE0061, clone 2.43), Transplantation Assay:Article Title: IL-1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma Article Snippet: .. Mice were injected intraperitoneally (i.p.) with 200 μg of specific monoclonal antibodies or inhibitors: anti-mouse CD8, InVivoPlus, clone YTS169.4 (BioXCell Cat. BP0117, RRID:AB_2894806) and the relative isotype control rat IgG2b, InVivoPlus, clone LTF-2 (BioXCell Cat. BP0090, RRID:AB_1107780); Transfection:Article Title: Cryoablation Activates the cGAS-STING-CXCL10 Axis in Macrophages to Enhance Anti-Tumor Immunity in NSCLC. Article Snippet: For T cell depletion, anti-mouse CD8 α (Selleck, A2102), anti-mouse CD4 (Selleck, A2101), or IgG2b isotype control (Selleck, A2116) was administered intraperitoneally at 200 μL per mouse. .. For NK cell depletion, Incubation:Article Title: Cryoablation Activates the cGAS-STING-CXCL10 Axis in Macrophages to Enhance Anti-Tumor Immunity in NSCLC. Article Snippet: For T cell depletion, anti-mouse CD8 α (Selleck, A2102), anti-mouse CD4 (Selleck, A2101), or IgG2b isotype control (Selleck, A2116) was administered intraperitoneally at 200 μL per mouse. .. For NK cell depletion, In Vivo:Article Title: Physiological activation of Aryl hydrocarbon receptor by food-derived ligands is essential for the efficacy of anti-PD1 therapy Article Snippet: .. For in vivo NK cell depletion, mice were treated intra-peritoneally with 120 μg of Saline:Article Title: Physiological activation of Aryl hydrocarbon receptor by food-derived ligands is essential for the efficacy of anti-PD1 therapy Article Snippet: .. For in vivo NK cell depletion, mice were treated intra-peritoneally with 120 μg of other:Article Title: Immunogenic tumor cell death and T-cell-derived IFN-γ elicit tumoricidal macrophages to potentiate OX40 immunotherapy. Article Snippet: Depletion studies to determine the contribution of immune cell subsets to combo therapy efficacy in humanized OX40 mice To deplete T cells, NK cells, or macrophages, the following antibodies were used with administered intraperitoneally: 300 μg of |